PI
STLN

PineBridge Investments’s Starling Oncology STLN Stock Holding History

PineBridge Investments’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,779
Closed -$41.7K – 669
2023
Q3 		$41.7K Buy
+29,779
New +$30.8K ﹤0.01% 644

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
CI
Cincinnati Insurance Fairfield, Ohio $6.94B AUM 20.24% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return
EPA
Element Pointe Advisors Miami, Florida $621M AUM 21.92% 1-Year Est. Return

PineBridge Investments's STLN Position: Q4 2023 in Review

PineBridge Investments sold out of Starling Oncology (STLN) in Q4 2023, closing a stake of 29,779 shares — an estimated $41.7K sold.

PineBridge Investments first reported a position in STLN in Q3 2023 and held it in 1 quarter. The position peaked at $41.7K in Q3 2023. 45 funds tracked by Wall St. Rank hold STLN as of Q4 2023.

  • PineBridge Investments reported no remaining Starling Oncology position as of Q4 2023 after selling out during the quarter.
  • PineBridge Investments sold 29,779 Starling Oncology shares in Q4 2023, an estimated $41.7K.
  • PineBridge Investments first reported a position in Starling Oncology in Q3 2023 and held it in 1 quarter.
  • PineBridge Investments's Starling Oncology position peaked at $41.7K in Q3 2023.
  • 45 funds tracked by Wall St. Rank held Starling Oncology as of Q4 2023.

Based on PineBridge Investments's 13F filing for Q4 2023, filed 13 Feb 2024.